MRS

Testing Novel 3D Mapping Technology to Transform Space Exploration and Benefit Industries on Earth

Retrieved on: 
Venerdì, Aprile 26, 2024
SpaceX, MRS, Apollo, SPACE, ISS, International Space Station, CRS, Safety, Map, NASA, Lunar Gateway, Software, United States national laboratories, Commercial Resupply Services, Research, 3D, Spacecraft, Environment, Human, CSIRO, Astrobee, ISS National Lab, SLAM, Parkes Observatory, Perception, Boeing, Mining, Planet, Algorithm, Kibo, Parkes, GPS, Surveying

Called the Multi-Resolution Scanner (MRS), the investigation will leverage NASA's free-flying robotic Astrobee system on the space station to test a novel 3D mapping technology that can produce detailed maps of remote environments.

Key Points: 
  • Called the Multi-Resolution Scanner (MRS), the investigation will leverage NASA's free-flying robotic Astrobee system on the space station to test a novel 3D mapping technology that can produce detailed maps of remote environments.
  • MRS creates 3D maps of various environments in unprecedented detail, like the space station or a lava tube on Mars.
  • Now, the organization is working on a project that will benefit not only future exploration missions but also key industries on Earth.
  • The MRS technology may also benefit several industries on Earth, such as mining and disaster relief.

5WPR Consumer Report Reveals Splurge Spending Behavior for Beauty & Personal Care on the Rise in 2024

Retrieved on: 
Lunedì, Aprile 22, 2024
Gen, Generation Z, Ageing, MRS, Beauty, Consumer culture, PR, 5WPR, ESOMAR, Research, Market Research Society, Retail

NEW YORK, April 22, 2024 /PRNewswire/ -- 5WPR, one of the largest independently owned PR firms in the U.S., reveals a 6% increase in consumer interest to splurge on beauty and personal care purchases in 2024 over the previous year. This marks the first time the category has entered the top five splurge categories in 5W's Consumer Culture Report history.

Key Points: 
  • This marks the first time the category has entered the top five splurge categories in 5W's Consumer Culture Report history.
  • Among consumers aged 16 to 24, beauty and personal care rank in the top three splurge categories, with a majority expressing their interest to splurge (57%).
  • "We're noticing a growing emphasis on consumer interest in prioritizing self-care, particularly beauty and personal care.
  • Looking back on 2023 spending, beauty and personal care claimed the fifth spot among all categories in which consumers reported spending their disposable income (29%).

Fiverr Industry Report Reveals that 90% of Tech Executives Hire Freelancers for High-Stress Periods

Retrieved on: 
Martedì, Marzo 26, 2024
Organization, Growth, Communication, MRS, Partnership, Integration, Acquisition, Software, Workforce, Market Research Society, Investment, Computer security, Creativity, Strategic Insights, Machine learning, ESOMAR, Medical device

The report offers a granular analysis of executives’ pain points, including in which quarter they feel the most stressed (Q3).

Key Points: 
  • The report offers a granular analysis of executives’ pain points, including in which quarter they feel the most stressed (Q3).
  • “When researching this report, we wanted to create a robust analysis of the problems that tech executives are facing, to provide them with tangible and actionable solutions.
  • Tech executives are responding to the industry’s growing demands by honing in on desired skills – specifically around emerging technologies.
  • How Tech Companies Leverage Freelance Talent to Build a Flexible Workforce:
    Nearly 90% of executives are open to leveraging freelancers during peak stress periods.

DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results

Retrieved on: 
Martedì, Marzo 19, 2024
Health, FDA, Clinical Trials, Pharmaceutical, Cardiology, Biotechnology, Epilepsy, TPA, AIS, Patient, Tissue plasminogen activator, Stroke, G&A, Investment, Therapy, Pharmacovigilance, Nektar Therapeutics, Research, KLK1, Biostatistics, NKTR, Trial of the century, DSM-IV codes, NIHSS, Amgen, Data management, Pharmacy, Food, Cubist Pharmaceuticals, Neurology, Rankine scale, Shanghai Pharmaceuticals, DMAC, Acquisition, University, Yale University, Psychiatry, MRS, ASTN, Takeda, Patent, Bangladesh Technical Education Board, Probability, Pharmaceutical industry

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal disease, today provided a business update and financial results for the year ended December 31, 2023.

Key Points: 
  • DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal disease, today provided a business update and financial results for the year ended December 31, 2023.
  • Management will host a conference call Wednesday, March 20, 2024, at 8:00 AM Eastern Time / 7:00 AM Central Time to discuss its business update and full year 2023 financial results.
  • Other income, net, was $1.9 million for the year ended December 31, 2023 compared to $0.4 million for 2022.
  • DiaMedica Management will host a conference call and webcast to discuss its business update and full year quarter 2023 financial results on Wednesday, March 20, 2024, at 8:00 AM Eastern Time / 7:00 AM Central Time:

Global Businesses Estimate Poor Mobile App Quality Costs Up to $2.49M in Lost Revenue

Retrieved on: 
Martedì, Marzo 19, 2024
Mobile, Wireless, Technology, Apps, Applications, Artificial Intelligence, Software, Automation, Organization, MRS, Intelligence, Ageing, App Store (iOS/iPadOS), Luigi, Artificial intelligence, AI, Market Research Society, IOS, ESOMAR, Android, Medical device

Tricentis, a global leader in continuous testing and quality engineering, today released the findings of a new global survey on the importance of mobile application quality and testing, with emphasis on the potential impact of artificial intelligence (AI), and low-code/no-code automation.

Key Points: 
  • Tricentis, a global leader in continuous testing and quality engineering, today released the findings of a new global survey on the importance of mobile application quality and testing, with emphasis on the potential impact of artificial intelligence (AI), and low-code/no-code automation.
  • Nearly all of those surveyed (86%) deem testing important to the quality and success of their organization’s mobile app development, however, just over a quarter (27%) believe their organization’s current mobile app development and testing strategy exceeds expectations.
  • This may be explained by the fact that nearly half (47%) of those surveyed also state they currently use manual testing for mobile applications.
  • Respondents also expect to achieve increased revenue (31%), improved productivity (32%), increased user retention (28%), and increased compatibility across devices (28%) through improved mobile application quality and testing.

IASO Bio Announces U.S. FDA Approval of Investigational New Drug Application for BCMA CAR-T Equecabtagene Autoleucel for Generalized Myasthenia Gravis

Retrieved on: 
Giovedì, Aprile 4, 2024
Vital capacity, MuSK protein, Glucocorticoid, NMPA, Hormone, GMG, Disease, Chinese, MRS, BCMA, Nervous system, Patient, SAN, Enzyme inhibitor, History, Female, Multiple myeloma, CRS, B cell, Biotechnology, IND, Phenotype, Investigational New Drug, QMG, Safety, Thymectomy, FDA, Food

The Chinese IND for this indication of Equecabtagene Autoleucel was approved by the NMPA in January this year.

Key Points: 
  • The Chinese IND for this indication of Equecabtagene Autoleucel was approved by the NMPA in January this year.
  • The 2 subjects were treated with a single infusion of Eque-cel at the doses of 1.0×106 CAR-T/Kg, respectively.
  • No immunomodulatory therapy other than low dose pyridostigmine (90 mg/day and 60 mg/day, respectively) was used during the follow-up period.
  • Anti-AChR antibodies, anti-Titin antibodies, and anti-MuSK antibodies decreased rapidly and maintained at very low levels in both subjects after infusion.

5W Consumer Culture Report Reveals Rising Interest in Spending on Travel and Experiences

Retrieved on: 
Giovedì, Marzo 28, 2024
PR, Ageing, 5WPR, Market Research Society, Travel, Perception, Research, ESOMAR, Communication, MRS, Overalls, Retail

Travel and experiences rank as the third most splurge-worthy category for consumers in 2024 (45%), with a notable 7% increase over last year.

Key Points: 
  • Travel and experiences rank as the third most splurge-worthy category for consumers in 2024 (45%), with a notable 7% increase over last year.
  • "Travel and experiences are big-ticket items, so it's not surprising for consumers to be looking to save when and where they can," said 5WPR Co-CEO, Dara A. Busch.
  • When shifting their attention to overall spending, consumers ranked travel and experiences as the third category where they spent most of their disposable income in 2023 (30%).
  • Consumers under the age of 34 are those who report they believe they are likely to spend most of their income this year on travel and experiences.

Layoffs Prompt Gen Z to Rethink Job Security and Careers, Fiverr Survey Reveals

Retrieved on: 
Mercoledì, Febbraio 28, 2024
Comfort, AI, Gen, Work, Generation Z, Travel, ESOMAR, Market Research Society, Ageing, Face, MRS, Partnership, Tobacco

Almost 70% of total Gen Z respondents are actively freelancing or plan to do so in the future.

Key Points: 
  • Almost 70% of total Gen Z respondents are actively freelancing or plan to do so in the future.
  • Nearly 40% of Gen Z freelancers are currently or willing to work full-time while 30% in a part-time capacity.
  • Among Gen Z respondents in the U.S., specifically, data showed:
    More Gen-Zers are pursuing stability through freelancing following a string of corporate layoffs.
  • Nearly 25% of Gen Z respondents now believe that freelancing is more stable than a traditional full-time job.

LRS Reports Unmatched Cooling Power in Stroke Patients - Results of SISCO Clinical Study Presented at 2024 ISC

Retrieved on: 
Martedì, Marzo 5, 2024
Research, Medical Devices, Neurology, Hospitals, Clinical Trials, Cardiology, Managed Care, Health, Science, TSS, Temperature, FDA, Food, ISC, IDE, Stroke, Manuscript, Conference, MRS, Safety, Patient, LRS, Pharmaceutical industry

On February 7, 2024, at this year’s International Stroke Conference (ISC), Life Recovery Systems (LRS) presented the results of its IDE-approved SISCO Study , in which ischemic stroke patients were rapidly cooled with the ThermoSuit System (TSS).

Key Points: 
  • On February 7, 2024, at this year’s International Stroke Conference (ISC), Life Recovery Systems (LRS) presented the results of its IDE-approved SISCO Study , in which ischemic stroke patients were rapidly cooled with the ThermoSuit System (TSS).
  • The TSS cooled patients to 34°C in a record time of 40 minutes in this pilot study.
  • No previous stroke cooling studies have had such rapid cooling or any trend for outcome improvements in patients.
  • Matt Center, LRS CEO, notes, “This study demonstrates the unmatched cooling power and excellent safety of the ThermoSuit system, while showing a strong trend for improved outcomes.

MRS Orders 30 Wabtec Evolution Series Locomotives

Retrieved on: 
Mercoledì, Febbraio 21, 2024
Natural Resources, Alternative Energy, Energy, Rail, Maritime, Logistics, Supply Chain Management, Transport, Mining, Minerals, Safety, Wabtec, GE Evolution Series, CO2, WAB, MRS, Federation

MRS Logística (MRSA-MB) and Wabtec Corporation (NYSE: WAB) announced an agreement for 30 new Evolution Series locomotives.

Key Points: 
  • MRS Logística (MRSA-MB) and Wabtec Corporation (NYSE: WAB) announced an agreement for 30 new Evolution Series locomotives.
  • According to Guilherme Segalla de Mello, president of MRS Logística, the fleet renewal is crucial for the company to improve efficiency and safety.
  • “By using a modern fleet of locomotives, we promote better energy efficiency in rail transport and contribute to improving our country’s logistics.
  • “This long-term contract highlights our vision of a greener railway network for Brazil.”
    Launched in 2022, the ES44ACi model locomotives are equipped with Evolution Series diesel engines, which produce 4,500 horsepower with just 12 cylinders.